BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
+12.44%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.87B
AUM Growth
+$7.87B
(+11%)
Cap. Flow
+$193M
Cap. Flow
% of AUM
2.46%
Top 10 Holdings %
Top 10 Hldgs %
73.35%
Holding
115
New
19
Increased
20
Reduced
44
Closed
6
Top Buys
| 1 |
ITMN
INTERMUNE INC
ITMN
|
$140M |
| 2 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$37.9M |
| 3 |
GEVA
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
|
$31.1M |
| 4 |
Heron Therapeutics
HRTX
|
$30.2M |
| 5 |
XNPT
XENOPORT, INC.
XNPT
|
$15.5M |
Top Sells
| 1 |
Arrowhead Research
ARWR
|
$38.7M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$35.1M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$25.4M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$8.81M |
| 5 |
Halozyme
HALO
|
$7.61M |
Sector Composition
| 1 | Healthcare | 43.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DYAX
26
DELISTED
DYAX CORPORATION
DYAX
| $22.7M | 0.29% |
2,531,766
+505,229
| +25% | +$4.54M |
|
|
AVNR
27
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $21.3M | 0.27% |
5,790,139
+361,548
| +7% | +$1.33M |
|
|
XNPT
28
DELISTED
XENOPORT, INC.
XNPT
| $20.9M | 0.27% |
4,034,112
+3,000,000
| +290% | +$15.5M |
|
|
PGNX
29
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $18.2M | 0.23% |
4,449,797
+249,797
| +6% | +$1.02M |
|
30
Neurogene
NGNE
$284M
| $15.4M | 0.2% |
+1,211,851
| New | +$15.4M |
|
31
TG Therapeutics
TGTX
$5.03B
| $14.9M | 0.19% |
2,160,965
-38,691
| -2% | -$267K |
|
|
KYTH
32
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $12.4M | 0.16% |
311,255
-1,936
| -0.6% | -$77K |
|
|
33
Arrowhead Research
ARWR
$3.84B
| $12M | 0.15% |
732,062
-2,357,938
| -76% | -$38.7M |
|
34
Insmed
INSM
$30.3B
| $10.5M | 0.13% |
554,050
-242,328
| -30% | -$4.61M |
|
35
Arbutus Biopharma
ABUS
$753M
| $10.4M | 0.13% |
484,156
-15,844
| -3% | -$341K |
|
36
Sangamo Therapeutics
SGMO
$161M
| $9.45M | 0.12% |
522,764
+98,456
| +23% | +$1.78M |
|
|
SGYP
37
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $9.34M | 0.12% |
1,758,271
-850,000
| -33% | -$4.71M |
|
38
Omeros
OMER
$284M
| $9.1M | 0.12% |
753,804
+145,400
| +24% | +$1.75M |
|
39
Prothena Corp
PRTA
$452M
| $8.82M | 0.11% |
230,142
-106,776
| -32% | -$4.09M |
|
|
MTEM
40
DELISTED
Molecular Templates, Inc.
MTEM
| $8.69M | 0.11% |
1,826,358
-26,041
| -1% | -$124K |
|
|
QLTI
41
DELISTED
QLT Inc
QLTI
| $8.54M | 0.11% |
1,535,863
| – | – |
|
|
WINT
42
DELISTED
Windtree Therapeutics Inc
WINT
| $7.85M | 0.1% |
3,652,117
-66,500
| -2% | -$143K |
|
43
Agios Pharmaceuticals
AGIO
$2.36B
| $7.83M | 0.1% |
199,893
-5,857
| -3% | -$229K |
|
44
Galectin Therapeutics
GALT
$288M
| $7.66M | 0.1% |
500,000
+399,400
| +397% | +$6.11M |
|
|
INFI
45
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $7.42M | 0.09% |
+624,050
| New | +$7.42M |
|
46
Neurocrine Biosciences
NBIX
$13.5B
| $7.21M | 0.09% |
+447,874
| New | +$7.21M |
|
|
STML
47
DELISTED
Stemline Therapeutics, Inc.
STML
| $6.9M | 0.09% |
338,671
-336,371
| -50% | -$6.85M |
|
|
AMBI
48
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $6.82M | 0.09% |
747,954
| – | – |
|
|
VXRT
49
DELISTED
Vaxart
VXRT
| $6.76M | 0.09% |
1,106,910
-23,203
| -2% | -$142K |
|
|
ARRY
50
DELISTED
Array Biopharma Inc
ARRY
| $6.74M | 0.09% |
1,433,797
-66,203
| -4% | -$311K |
|